Abstract:Primary hyperparathyroidism (pHPT) is the most common cause of hypercalcemia and currently the only definitive treatment is surgery. Although the success rate of parathyroidectomy is over 95% in experienced centers, surgical failure is the most common complication today. Persistent HPT (perHPT) is defined as persistence of hypercalcemia after parathyroidectomy or recurrence of hypercalcemia within the first 6 months, and recurrence of hypercalcemia after a normocalcemic period of more than 6 months is defined as recurrent HPT (recHPT). In the literature, perHPT is reported to be 2-22%, and the rate of recHPT is 1-15%. perHPT is often associated with misdiagnosed pathology or inadequate resection of hyperfunctioning parathyroid tissue, recHPT is associated with newly developing pathology from potentially pathologically natural tissue left in situ at the initial surgery. In the pre-operative evaluation, the initial diagnosis of pHPT and the diagnosis of perHPT or rec HPT should be confirmed in patients who are evaluated with a pre-diagnosis (suspect) of perHPT and recHPT. Surgery is recommended if it meets any of the recommendations in surgical guidelines, as in patients with pHPT, and there are no surgical contraindications. The first preoperative localization studies, surgical notes, operation drawings, if any, intraoperative PTH results, pathological results, and post-operative biochemical results of these patients should be examined. Localization studies with preoperative imaging methods should be performed in all patients with perHPT and recHPT with a confirmed diagnosis and surgical indication. The first-stage imaging methods are ultrasonography and Tc99m sestamibi single photon tomography Tc99mMIBI SPECT or hybrid imaging method, which is combined with both single-photon emission computed tomography and computed tomography (SPECT/CT). The combination of USG and sestamibi scintigraphy increases the localization of the pathological gland. In the secondary stage, Four-Dimensional computer tomography (4D-CT) or dynamic 4-dimensional Magnetic Resonance Imaging (4D-MRI) can be applied. It is focused on as a secondary stage imaging method, especially when the lesion cannot be detected by conventional methods. Positron Emission Tomography (PET) and PET/CT examinations with 11C-choline or 18F-fluorocholine are promising imaging modalities. Invasive examinations can rarely be performed in patients in whom suspicious, incompatible or pathological lesion cannot be detected in noninvasive imaging methods. Bilateral jugular vein sampling, selective venous sampling, parathyroid arteriography, imaging-guided fine-needle aspiration biopsy, and parathormone washout are invasive methods.

Surgical Exploration Should Be Tried for Patients with Primary Hyperparathyroidism Even the Imaging Localization is Uncertain

Preoperative Localization and Minimally Invasive Management of Primary Hyperparathyroidism Concomitant with Thyroid Disease

Surgery for nonlocalizing hyperparathyroidism in high volume center

The clinical analysis of surgical treatment of primary hyperparathyroidism

Primary Hyperparathyroidism: Is Image Localization Alone Sufficient to Ensure Long-Term Cure in Unifocal Disease?

The role of anatomical and functional orientation in identification of parathyroid glands for patients with parathyroidectomy

Factors That Affect the Sensitivity of Imaging Modalities in Primary Hyperparathyroidism

Surgical diagnosis and treatment of primary hyperparathyroidism (report of 24 cases)

Persistent and Recurrent Primary Hyperparathyroidism: Etiological Factors and Pre-Operative Evaluation

Imaging Diagnosis of Primary Hyperparathyroidism

Use of 99Mtc-Sestamibi SPECT/CT Imaging in Predicting the Degree of Pathological Hyperplasia of the Parathyroid Gland: Semi-Quantitative Analysis.

Diagnosis and Treatment for Primary Hyperparathyroidism with Concomitant Thyroid Diseases

[Diagnosis and Treatment of Parathyroid Carcinoma: 9 Cases Report and Literature Review].

Which Localizing Strategy is the Most Cost-Effective in Reoperative Primary Hyperparathyroidism?

ROLE OF ~(99)Tc~m-SESTAMIBI DUAL-PHASE PARATHYROID SCINTIGRAPHY IN PREOPERATIVE LOCALIZATION IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism

Pitfalls of DualTracer 99m-Technetium (Tc) Pertechnetate and Sestamibi Scintigraphy before Parathyroidectomy: Between Primary-Hyperparathyroidism-Associated Parathyroid Tumour and Ectopic Thyroid Tissue

Preoperative Diagnosis and Prognosis in 40 Parathyroid Carcinoma Patients

Strategy for the diagnosis and treatment of bone diseases caused by primary hyperparathyroidism

A Case of Hypercalcemia Complicated with Hyperthyroidism

[Clinical Analysis of Primary Hyperparathyroidism with Kidney Stones: 23 Cases Report].